Skip to content

Randomized control study comparing reconstruction procedures after esophagectomy -gastric tube reconstruction vs gastric tube reconstruction with duodenal diversion plus Roux-en Y anastomosis-

Randomized control study comparing reconstruction procedures after esophagectomy -gastric tube reconstruction vs gastric tube reconstruction with duodenal diversion plus Roux-en Y anastomosis- - Randomized control study comparing reconstruction procedures after esophagectomy -gastric tube reconstruction vs gastric tube reconstruction with duodenal diversion plus Roux-en Y anastomosis-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016949
Enrollment
60
Registered
2015-03-31
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with resectable thoracic esophageal cancer who are planned to undergo esophagectomy with gastric tube reconstruction and 2 or 3 field lymphadenectomy

Interventions

After patients are randomly allocated to RY and Non-RY groups, RY group undergo gastric tube reconstruction with duodenal diversion plus Roux-en anastomosis. After patients are randomly allocated to R

Sponsors

Osaka Medical Center for Cancer and Cardiovascular Diseases
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. histologically proven esophageal cancer by endoscopic biopsy 2. resectable cases, cT1b-3,Nany,M0 by preoperative staging, 3. preserve normal swallowing function and can eat and drink 4. 80 years old or younger 5. PS 0-2 6. Vital organ functions within 7days before entry are preserved. 7. Written informed consentis ontained from each patient.

Exclusion criteria

Exclusion criteria: 1. synchronous other malignant cancer within 1 year 2. Miocardial infarction, Master two steppositive on ECG 3. preoperative respiratory test, FEV1.0 is less than 50% 4. prior chemotherapy or radiationtherapy within 6 months 5. prior gastric or intestinal resection 6. severe absorptive disturbance 7. severe postoperative complications (anastomotic leakage, ileus, intraabdominal abcess, pneumonia, etc) 8. pregnant 9. other severe co-morbidities 10. In case where surgeon judge that entry to the study is impossible.

Design outcomes

Primary

MeasureTime frame
Postoperative QOL at 1year assessed by DAUGS-32 questionare

Countries

Japan

Contacts

Public ContactKazuyuki Itoh

Osaka Medical Center for Cancer and Cardiovascular Diseases Research Institute

kbyori01@mc.pref.osaka.jp06-6977-6151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026